What Is Astralis Planning to Sell to Recover Financially?

What Is Astralis Planning to Sell to Recover Financially?

29. April 2025 by Francisco Villafana

Astralis, once one of the most dominant organizations in Counter-Strike, is now reportedly facing financial challenges following years of underwhelming results in Counter-Strike 2. According to sources confirmed by HLTV, the organization is exploring the sale of several key assets to stabilize its financial standing.

Astralis Plans to Sell Key Assets Worth Millions

According to insider Varizan, Astralis is currently preparing to offload a range of intellectual and operational assets. These include not only their CS2 team, but also significant parts of their brand identity and internal resources.

Assets Astralis Plans to Sell:

  • Entire CS2 roster

  • Astralis brand and trademark

  • Intellectual property and rights

  • 12 non-esports staff members

  • Pending sponsorship contract

Estimated value of the package: $2 to $3 million USD.

This move aims to generate quick revenue while streamlining the organization’s operations in a tough competitive climate.

LEC Slot Deal With Karmine Corp Will Remain Unaffected

A major concern among fans is whether the sale will impact Astralis’ LEC partnership with Karmine Corp. The two organizations entered a deal in 2023, giving Karmine Corp a 66.67% stake in Astralis’ LEC slot. That stake will reach 100% ownership by 2031.

Insiders confirm that this agreement remains intact, and no changes will affect the future participation of Karmine Corp in the League of Legends European Championship.

Karmine Corp Astralis LEC

Source: LEC

Why Is Astralis Struggling Financially?

The primary factor is the decline in competitive performance. Astralis has failed to qualify for a CS Major since 2022, missing out on key revenue from prize pools and sponsorship deals.

As highlighted by Esports.net, consistent results are essential for orgs to maintain commercial partnerships and fan engagement — two pillars that have weakened for Astralis.